ZXH-1-161（Cat No.:I038693）is a selective small-molecule inhibitor targeting the STAT3 (Signal Transducer and Activator of Transcription 3) signaling pathway, which plays a pivotal role in cancer progression, inflammation, and immune regulation. By blocking STAT3 phosphorylation and dimerization, ZXH-1-161 inhibits its nuclear translocation and transcriptional activity, leading to the suppression of oncogenic gene expression. This compound has shown promising anticancer effects by inducing apoptosis and inhibiting tumor cell proliferation. ZXH-1-161 is also a valuable tool for studying STAT3-driven mechanisms and holds therapeutic potential for treating STAT3-dependent cancers and inflammatory diseases.